SanegeneBio entered into a licensing collaboration with Eli Lilly and Company as part of a Licensing Collaboration on not available.
Deal value was 3700000000 (source: AI Estimation) Sector: Biotechnology; Location: Global.
On the seller side, counsel was not available; lawyers included Asher Rubin, James Lu, Jean Qiu, Cassidy Pomeroy-Carter, Pan Chen, Rachel Kleinberg, Jonathan Westreich.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Sidley advises SanegeneBio in up to US$1.2 billion global research and licensing collaboration with Eli Lilly and Company | The Sponsor - The Sponsor
